Skip Navigation


  • Emory University School of Medicine’s Department of Hematology & Medical Oncology is leading the fight against cancer through uncompromised patient care and cutting edge research. As part of the National Cancer Institute designated Winship Cancer Institute, the Department is focused on clinical and basic research, teaching, and delivering outstanding hematology and oncology clinical services to Emory patients.

Hero Shot

Winship News

New Funding Challenges

For several years, Winship Cancer Institute of Emory University has been working to keep its cancer research and clinical trials programs going despite federal budget cuts. Continue Reading>>

Winship Newsroom | Hematology/Medical Oncology News

Featured Researcher

Dr. Galipeau Dr. Jacques Galipeau is a Professor of Hematology and Medical Oncology, Pediatrics & Medicine, Emory School of Medicine and is Co-Director of the Winship Cancer Institute Tumor Immunology-Immunotherapy initiative as well as Director of the Emory Personalized Immunotherapy Center (EPIC) and is a Georgia Cancer Coalition Distinguished Cancer Scholar. Dr. Galipeau came to Emory University in October 2009 where he established the Emory Personalized Immunotherapy Center [EPIC] whose mission is to develop evidence- based and innovative personalized cell therapies for immune and malignant disorders.  Read More>>